Capgemini and Google Cloud expand strategic partnership to accelerate AI adoption at scale by providing trusted and secure sovereign solutions
Press contact:Antara Nandy Tel.:+ 91 9674515119E-mail: antara.nandy@capgemini.com Capgemini and Google Cloud expand…
New York CEO Dan Herbatschek of Ramsey Theory Capital Delivers New Real-Time Governance for Enterprise AI Systems as AI Safety Laws Accelerate
NEW YORK, Feb. 07, 2026 (GLOBE NEWSWIRE) -- New York CEO Dan…
Hemex Health Receives FDA Breakthrough Device Designation for Gazelle Hb Variant Test
PORTLAND, Ore., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Hemex Health, a medical…
Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Appoints Dr. John E. Brandenburg, Ph.D. as Chief Technology Officer
SOUTHLAKE, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Renewal Fuels, Inc. (OTC:…
Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2026 16:01 ET | Source: Ocular Therapeutix, Inc. BEDFORD, Mass.,…
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2026 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery
New facility will enable end‑to‑end discovery across key disease areas and technology…
The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of…
Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met…
Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
February 06, 2026 17:17 ET | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS,…
